|
Market Closed -
Euronext Bruxelles
23:55:00 21/08/2026 HKT
|
After hours 01:58:43 | |||
| 221.70 EUR | +1.74% |
|
221.50 | -0.09% |
| 08-20 | Cancer vaccines finally garner the spotlight |  |
| 08-19 | Danish Pharma H. Lundbeck Expects No Slowdown for Primary Growth Driver Brands | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UCB | Biopharmaceuticals | +1.74% | +4.43% | -7.08% | +11.41% | +123.13% | 48.52B |  | |  |
- Stock Market
- Stocks
- UCB Stock
- Charts UCB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
